Skip to content

Matrix Capital Management Company, LP

Follow

13F filer, CIK 1410830, Portsmouth, NH

Matrix Capital Management Company, LP reported $57,616,042 across 2 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-26-000728

Period
2025-12-31
Reported value
$57.6M
Holdings
2
Top 10 weight
100%
New
0
Sold out
1

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MAZEreduced-1,173,684-$48.6M
ZNTLexited-13,959,973-$21.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001172661-26-000728, largest first. % of portfolio is the value over $57,616,042, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,922,870 shares; 2024Q4: 6,922,870 shares; 2025Q1: 6,922,870 shares; 2025Q2: 6,922,870 shares; 2025Q3: 6,922,870 shares; 2025Q4: 6,922,870 shares 6,922,870$37.7M65.48%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 2,486,184 shares; 2025Q2: 2,486,184 shares; 2025Q3: 1,653,684 shares; 2025Q4: 480,000 shares 480,000$19.9M34.52%-1,173,684Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ZNTLZENTALIS PHARMACEUTICALS INC13,959,973$21.1Mshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-000728 base2026-02-13acceptance time not in the bulk data set